Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Population pharmacokinetic model of ibrutinib, a Bruton's tyrosine kinase inhibitor, for the treatment of B-cell malignancies Marostica, E., Sukbuntherng, J., Loury, D., Jong, J. D., de Trixhie, X., Vermeulen, A., de Nicolao, G., O'Brien, S., Byrd, J. C., Advani, R., McGreivy, J., Poggesi, I. AMER ASSOC CANCER RESEARCH. 2014
View details for DOI 10.1158/1538-7445.AM2014-4634
View details for Web of Science ID 000349910203108